Swiss stocks - Factors to watch on March 15

PolyPeptide AG

15/03/2022 06:00

BERLIN/ZURICH, March 15 (Reuters) - Here are some of the
main factors that may affect Swiss stocks on Tuesday:
    
    COMPANY STATEMENTS
    * Bystronic AG  BYS.S  reported full-year sales of 939.3
million Swiss francs, up 17.2%.  urn:newsml:reuters.com:*:nASM0003KJ
    * Crealogix  CLXN.S  said it recorded a net loss of CHF 7.7
million before goodwill depreciation in the first half of
2021/2022.  CLXN.S 
    * Dufry  DUFN.S  said it extended its duty-free concession
at Bali's I Gusti Ngurah Rai International Airport for another
six years.  DUFN.S 
    * Helvetica Property Investors  HSCF.S  said rental income
increased by 8.2% to around 42 million Swiss francs last year.
 HSCF.S 
    * Komax  KOMN.S  said it would propose a dividend of 4.50
Swiss francs per share for 2021 after profitability improved. it
said the situation in Ukraine led to high customer demand for
replacement machines.  KOMN.S  
    * Metall Zug  METN.S  said its full-year net income was 53.3
million Swiss francs.  urn:newsml:reuters.com:*:nFWN2VH1A4
    * Newron  NWRN.S  reported a net loss of 14.9 million euros
in 2021, compared to 21.0 million euros in 2020. It said total
available cash resources would fund the company's planned
development programs and operations into 2024.  NWRN.S 
    * Polypeptide  PPGN.S  said its result for the year rose
50.8% to 47.3 million euros with basic EPS of 1.47 euros.
 PPGN.S 
    * Relief Therapeutics  RLFB.S  said its subsidiary APR 
signed a binding term sheet with Meta Healthcare Ltd. to acquire
commercialization rights outside the United Kingdom and Ireland
for a novel dosage form of a prescription drug against
phenylketonuria.  RLFB.S 
    * Santhera Pharmaceuticals  SANN.S  and ReveraGen BioPharma,
Inc will present efficacy and tolerability data with vamorolone
in Duchenne muscular dystrophy at the 2022 Muscular Dystrophy
Association Clinical & Scientific Conference in March.  SANN.S  
    * Stadler Rail  SRAIL.S  said it expected sales of 3.7 to
4.0 billion Swiss francs with a stable EBIT margin in 2022.
 urn:newsml:reuters.com:*:nFWN2VH1CS
    * Sensirion Holding  SENSI.S  said it had EBITDA of 91.1
million Swiss francs last year.  urn:newsml:reuters.com:*:nASM0003KK
    * Tecan Group  TECN.S  reported net profit of 121.7 million
Swiss francs for the full year.  urn:newsml:reuters.com:*:nASM0003KI    
    * V-ZUG GROUP  VZUG.S  said its full-year net sales rose to
623.7 million Swiss francs, from 569.4 million the year before.
 urn:newsml:reuters.com:*:nFWN2VH1A4
    
        
    ANALYSTS' VIEWS
    SWATCH GROUP AG  UHR.S : RBC CUTS TARGET PRICE TO CHF 260
FROM CHF 285
    COMPAGNIE FINANCIERE RICHEMONT SA  CFR.S : RBC CUTS TARGET
PRICE TO CHF 148 FROM CHF 173
    SIG COMBIBLOC GROUP AG  SIGNC.S : JEFFERIES CUTS TARGET
PRICE TO CHF 27 FROM CHF 30

    ECONOMY
    
    February producer/import price index data due at 0730 GMT

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))